450.37
price down icon0.19%   -0.86
after-market Dopo l'orario di chiusura: 452.50 2.13 +0.47%
loading

Vertex Pharmaceuticals Inc Azioni (VRTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
6.87%
2,690.60
2,517.70 2,483.50 2,493.20 2,374.80
Cost Of Revenue
6.90%
342.60
368.00 318.70 308.60 266.90
Gross Profit
9.22%
2,348.00
2,149.70 2,164.80 2,184.60 2,107.90
Operating Expenses
4.07%
1,208.50
1,161.20 1,126.70 1,158.20 1,328.90
Benefits Costs and Expenses
3.02%
1,411.50
1,370.10 1,304.30 1,331.70 1,483.30
Costs And Expenses
1.43%
1,551.10
1,529.20 1,445.40 1,466.80 1,595.80
Provision For Loan, Lease, And Other Losses
-
- - - -
Operating Income/Loss
15.28%
1,139.50
988.50 1,038.10 1,026.40 779.00
Net Interest Income/Expense
1.89%
-10.40
-10.60 -10.90 -11.20 -11.40
Interest Income/Expense After Provision For Losses
1.89%
-10.40
-10.60 -10.90 -11.20 -11.40
Income/Loss From Continuing Operations Before Tax
11.46%
1,279.10
1,147.60 1,179.20 1,161.50 891.50
Income Tax Expense/Benefit
0.39%
179.50
178.80 143.90 245.80 191.70
Income/Loss From Continuing Operations After Tax
13.50%
1,099.60
968.80 1,035.30 915.70 699.80
Net Income/Loss
13.50%
1,099.60
968.80 1,035.30 915.70 699.80
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
258.20
- 258.00 257.70 257.40
Diluted Average Shares
261.00K%
261.10
0.10 260.60 260.40 260.30
Basic Earnings Per Share
13.30%
4.26
3.76 4.01 3.55 2.72
Diluted Earnings Per Share
13.48%
4.21
3.71 3.97 3.52 2.69
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$744.50
price up icon 0.15%
$596.74
price up icon 0.83%
$246.80
price down icon 0.80%
$108.23
price up icon 5.96%
$194.56
price up icon 0.15%
Capitalizzazione:     |  Volume (24 ore):